Trademark Search in Canada

TYRLIBRIA

View On IC.GC.CA

CANCELLED

Last Applicant/ Owned by

Oyster Point Pharma, Inc.

202 Carnegie Center, Suite 109Princeton NJ 08540

Serial Number

2073602 filed on 14^th Nov 2020

Registration Number

TMA1128577 registered on 11^th May 2022

Registration expiry Date

14^th Nov 2030

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

M5H3Y2

TYRLIBRIA

Trademark usage description

pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutic Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of dry eye disease; Pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases.

Classification kind code

Mark Details

Serial Number

2073602

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 19^th Jan 2022	Approved
Submitted for opposition 22 on 13^th Jan 2022	Search Recorded
Submitted for opposition 256 on 28^th Oct 2021	Notification of Possible Opposition Sent
Submitted for opposition 256 on 26^th Oct 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 2^th Mar 2021	Agent Changed
Submitted for opposition 257 on 24^th Dec 2020	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 23^rd Dec 2020	Formalized
Submitted for opposition 1 on 23^rd Dec 2020	Created
Submitted for opposition 228 on 14^th Nov 2020	International Registration
Submitted for opposition 30 on 14^th Nov 2020	Filed